^
No biomarker
Bladder Cancer
cisplatin
Sensitive
:
A1
No biomarker
Bladder Cancer
EP
Sensitive
:
A2
PD-L1 expression
Bladder Cancer
atezolizumab
Sensitive
:
A2
PD-L1 expression
Bladder Cancer
pembrolizumab
Sensitive
:
A2
No biomarker
Bladder Cancer
capecitabine
Sensitive
:
A2
No biomarker
Bladder Cancer
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Bladder Cancer
cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV
Sensitive
:
A2
No biomarker
Bladder Cancer
5-fluorouracil
Sensitive
:
A2
No biomarker
Bladder Cancer
5-fluorouracil + mitomycin
Sensitive
:
A2
No biomarker
Bladder Cancer
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Bladder Cancer
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Bladder Cancer
enfortumab vedotin
Sensitive
:
A2
No biomarker
Bladder Cancer
docetaxel
Sensitive
:
A2
No biomarker
Bladder Cancer
paclitaxel
Sensitive
:
A2
No biomarker
Bladder Cancer
gemcitabine + ifosfamide + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Bladder Cancer
paclitaxel + gemcitabine
Sensitive
:
A2
No biomarker
Bladder Cancer
gemcitabine
Sensitive
:
A2
No biomarker
Bladder Cancer
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Bladder Cancer
cisplatin + gemcitabine
Sensitive
:
A2
No biomarker
Bladder Cancer
avelumab
Sensitive
:
A2
No biomarker
Bladder Cancer
sacituzumab govitecan-hziy
Sensitive
:
A2
No biomarker
Bladder Cancer
inbakicept
Sensitive
:
B
PD-L1 expression
Bladder Cancer
nivolumab
Sensitive
:
B
PD-L1 expression
Bladder Cancer
durvalumab
Sensitive
:
C1
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our